Investigational New Drugs - Springer

Investigational New Drugs - Springer

Latest Articles

1. 
   PHASE I STUDIES

   Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2)

   Ruud van der Noll, Agnes Jager, Joo Ern Ang, Serena Marchetti… (October 2019)
2. 
   SHORT REPORT

   Phase II study of apatinib, a novel tyrosine kinase inhibitor targeting tumor angiogenesis, as second-line treatment for recurrent or advanced cervical cancer patients

   Linlin Zhang, Liang Chen, Hao Yu (October 2019)
3. 
   PHASE II STUDIES

   Impact of l-carnitine on imatinib-related muscle cramps in patients with gastrointestinal stromal tumor

   Heejung Chae, Min-Hee Ryu, Jungeun Ma, Moyeol Beck… (October 2019)